Cocrystal Pharma Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
138.70
199.00
192.00
201.00
101.00
50
Gross Income
138.70
199.00
192.00
201.00
101.00
50
SG&A Expense
3,162.30
5,609.00
53,316.00
105,618.00
8,161.00
8,969
EBIT
3,301.00
5,808.00
53,508.00
105,819.00
8,262.00
9,019
Unusual Expense
4,526.70
4,784.00
10,434.00
1,426.00
907.00
53,493
Non Operating Income/Expense
470.50
777.00
1,608.00
1.00
138.00
60
Interest Expense
3,342.00
-
-
-
-
58
Pretax Income
11,640.10
151.00
65,370.00
104,268.00
7,493.00
62,630
Income Tax
-
52.00
15,248.00
29,394.00
6,880.00
13,582
Consolidated Net Income
11,640.10
99.00
50,122.00
74,874.00
613.00
49,048
Net Income
11,640.10
99.00
50,122.00
74,874.00
613.00
49,048
Net Income After Extraordinaries
3,658.30
99.00
50,122.00
74,874.00
613.00
49,048
Net Income Available to Common
24,424.50
99.00
50,122.00
74,874.00
613.00
49,048
EPS (Basic)
9.90
0.01
2.40
3.30
0.03
1.75
Basic Shares Outstanding
2,416.70
10,892.60
21,010.50
23,517.60
24,128.40
28,009
EPS (Diluted)
9.83
0.21
2.39
3.18
0.03
1.75
Diluted Shares Outstanding
2,416.70
10,925.10
21,010.50
23,533.30
24,128.40
28,009
EBITDA
3,162.30
5,609.00
53,316.00
105,618.00
8,161.00
8,969
Non-Operating Interest Income
-
96.00
180.00
126.00
-
-
Preferred Dividends
4,136.00
-
-
-
-
-
About Cocrystal Pharma
View Profile
